摘要 |
A novel crystalline form of Perindopril erbumine monohydrate of Formula (III) of characteristic 2? values 8.87, 9.43, 9.60, 15.36, 15.96, 16.02, 19.97, 21.00, 21.13, 21.5, 22.14, 24.13, and 26.48. More particularly the present invention relates to a process for the preparation of the novel crystalline form of Perindopril erbumine monohydrate of Formula (III). |
申请人 |
ARCH PHARMALABS LIMITED;UJAGARE, ASHISH;KOCHREKAR, D., A.;SARJEKAR, PUSHPALATA |
发明人 |
UJAGARE, ASHISH;KOCHREKAR, D., A.;SARJEKAR, PUSHPALATA |